These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31388746)

  • 1. The usefulness and prognostic value of Memorial Symptom Assessment-Short Form and Condensed Memorial Symptom Assessment Scale in assessment of lung cancer patients.
    Bircan HA; Yalcin GS; Fidanci S; Karaibrahimoglu A; Tuglu HC
    Support Care Cancer; 2020 Apr; 28(4):2005-2014. PubMed ID: 31388746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical utility of Memorial Symptom Assessment-Short Form and Condensed Memorial Symptom Assessment Scale in Turkish lung cancer patients.
    Yüceege M; Sanisoğlu B; Fırat H; Ersoy Y; Sevgi E; Kurt EB
    Clin Respir J; 2015 Apr; 9(2):221-7. PubMed ID: 25849299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights in symptom assessment: the Chinese Versions of the Memorial Symptom Assessment Scale Short Form (MSAS-SF) and the Condensed MSAS (CMSAS).
    Lam WW; Law CC; Fu YT; Wong KH; Chang VT; Fielding R
    J Pain Symptom Manage; 2008 Dec; 36(6):584-95. PubMed ID: 18434076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shorter symptom assessment instruments: the Condensed Memorial Symptom Assessment Scale (CMSAS).
    Chang VT; Hwang SS; Kasimis B; Thaler HT
    Cancer Invest; 2004; 22(4):526-36. PubMed ID: 15565810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construct Validity of the Spanish Versions of the Memorial Symptom Assessment Scale Short Form and Condensed Form: Rasch Analysis of Responses in Oncology Outpatients.
    Llamas-Ramos I; Llamas-Ramos R; Buz J; Cortés-Rodríguez M; Martín-Nogueras AM
    J Pain Symptom Manage; 2018 Jun; 55(6):1480-1491. PubMed ID: 29499234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Baseline Edmonton Symptom Assessment Scale Scores on Treatment and Survival in Patients With Advanced Non-small-cell Lung Cancer.
    McGee SF; Zhang T; Jonker H; Laurie SA; Goss G; Nicholas G; Albaimani K; Wheatley-Price P
    Clin Lung Cancer; 2018 Jan; 19(1):e91-e99. PubMed ID: 28666762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability and Validity of the Korean Memorial Symptom Assessment Scale-Short Form in Gynecological Cancer Patients.
    Nho JH; Kim SR; Chang VT; Nam JH
    J Pain Symptom Manage; 2018 Jan; 55(1):101-107. PubMed ID: 28865872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Simplified Chinese Version of the Memorial Symptom Assessment Scale-Short Form Among Cancer Patients.
    Fu L; Hu Y; Lu Z; Zhou Y; Zhang X; Chang VT; Yang Y; Wang Y
    J Pain Symptom Manage; 2018 Jul; 56(1):113-121. PubMed ID: 29627566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The memorial symptom assessment scale short form (MSAS-SF).
    Chang VT; Hwang SS; Feuerman M; Kasimis BS; Thaler HT
    Cancer; 2000 Sep; 89(5):1162-71. PubMed ID: 10964347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does age influence the symptom experience of lung cancer patients prior to surgery?
    Oksholm T; Miaskowski C; Kongerud JS; Cooper B; Paul SM; Laerum L; Rustoen T
    Lung Cancer; 2013 Oct; 82(1):156-61. PubMed ID: 23916857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptom Burden and Functional Dependencies Among Cancer Patients in Botswana Suggest a Need for Palliative Care Nursing.
    Lazenby M; Sebego M; Swart NC; Lopez L; Peterson K
    Cancer Nurs; 2016; 39(1):E29-38. PubMed ID: 25881812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress.
    Browall M; Kenne Sarenmalm E; Nasic S; Wengström Y; Gaston-Johansson F
    J Pain Symptom Manage; 2013 Jul; 46(1):131-41. PubMed ID: 23195392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability and Validity of the Spanish Version of the Memorial Symptom Assessment Scale in Oncology Patients.
    Llamas Ramos I; Llamas Ramos R; Martín Nogueras AM; Alvarado Omenat JJ; Calvo Arenillas JI; Fonseca Sánchez E; Cortés Rodríguez M
    J Pain Symptom Manage; 2016 Dec; 52(6):884-891. PubMed ID: 27693903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementing the Condensed Memorial Symptom Assessment Scale on an Inpatient Oncology Unit.
    Englehart V; Noonan D; Schneider SM; Thompson J
    Clin J Oncol Nurs; 2022 Feb; 26(1):E1-E6. PubMed ID: 35073294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of the memorial symptom assessment scale-short form psychological subscales in advanced cancer patients.
    Webber K; Davies AN
    J Pain Symptom Manage; 2011 Nov; 42(5):761-7. PubMed ID: 21530154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of patient-reported symptom interference in patients with late-stage lung cancer.
    Barney BJ; Wang XS; Lu C; Liao Z; Johnson VE; Cleeland CS; Mendoza TR
    Qual Life Res; 2013 Oct; 22(8):2143-50. PubMed ID: 23371797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.
    Ni XF; Wu P; Wu CP; Ji M; Wu J; Gu XF; Jiang ZX
    Asia Pac J Clin Oncol; 2015 Dec; 11(4):e22-30. PubMed ID: 24889374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The memorial symptom assessment scale: modified for use in understanding family caregivers' perceptions of cancer patients' symptom experiences.
    Lobchuk MM
    J Pain Symptom Manage; 2003 Jul; 26(1):644-54. PubMed ID: 12850647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The psychometric properties of the Hebrew version of the Memorial Symptom Assessment scale (MSAS-Heb) in patients with breast cancer.
    Pud D
    J Pain Symptom Manage; 2015 Apr; 49(4):790-5. PubMed ID: 25261638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptoms in the month before death for stage 5 chronic kidney disease patients managed without dialysis.
    Murtagh FE; Addington-Hall J; Edmonds P; Donohoe P; Carey I; Jenkins K; Higginson IJ
    J Pain Symptom Manage; 2010 Sep; 40(3):342-52. PubMed ID: 20580200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.